JPS6310712B2 - - Google Patents
Info
- Publication number
- JPS6310712B2 JPS6310712B2 JP6520077A JP6520077A JPS6310712B2 JP S6310712 B2 JPS6310712 B2 JP S6310712B2 JP 6520077 A JP6520077 A JP 6520077A JP 6520077 A JP6520077 A JP 6520077A JP S6310712 B2 JPS6310712 B2 JP S6310712B2
- Authority
- JP
- Japan
- Prior art keywords
- glucopyranosyl
- deoxy
- glucopyranoside
- nitrosouride
- chloroethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000000625 hexosyl group Chemical group 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000002246 antineoplastic agent Substances 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 229940041181 antineoplastic drug Drugs 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 235000010288 sodium nitrite Nutrition 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 230000003394 haemopoietic effect Effects 0.000 description 3
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 230000000719 anti-leukaemic effect Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000009935 nitrosation Effects 0.000 description 2
- 238000007034 nitrosation reaction Methods 0.000 description 2
- 210000003200 peritoneal cavity Anatomy 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 239000004157 Nitrosyl chloride Substances 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 230000008378 epithelial damage Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 150000002402 hexoses Chemical group 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 208000003747 lymphoid leukemia Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- VPCDQGACGWYTMC-UHFFFAOYSA-N nitrosyl chloride Chemical compound ClN=O VPCDQGACGWYTMC-UHFFFAOYSA-N 0.000 description 1
- 235000019392 nitrosyl chloride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6520077A JPS53149932A (en) | 1977-06-01 | 1977-06-01 | 2-(3-alkylnitrosoureido)-hexapyranoside derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6520077A JPS53149932A (en) | 1977-06-01 | 1977-06-01 | 2-(3-alkylnitrosoureido)-hexapyranoside derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS53149932A JPS53149932A (en) | 1978-12-27 |
| JPS6310712B2 true JPS6310712B2 (enrdf_load_stackoverflow) | 1988-03-08 |
Family
ID=13280025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6520077A Granted JPS53149932A (en) | 1977-06-01 | 1977-06-01 | 2-(3-alkylnitrosoureido)-hexapyranoside derivatives |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS53149932A (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5441821A (en) * | 1977-09-05 | 1979-04-03 | Nippon Shinyaku Co Ltd | 2-(3-alkylnitrosoureido)glucopyranoside derivative |
-
1977
- 1977-06-01 JP JP6520077A patent/JPS53149932A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS53149932A (en) | 1978-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104817605A (zh) | 2-(1’,2’,3’-三氮唑-4’-氧苄基)-1,3,4,6-o-乙酰基-d-葡萄糖及其制备方法和应用 | |
| US4636508A (en) | 5-pyrimidinecarboxyamides and treatment of leukemia therewith | |
| CN117462558A (zh) | 反式-[四氯双(1h-吲唑)钌(iii)]及其组合物的制备 | |
| GB2073752A (en) | 2,6-diaminobularines | |
| US4239905A (en) | 1-β-D-Arabinofuranosylcytosine-5'-oleyl phosphate and salts thereof | |
| JPH08506835A (ja) | ３′−アジリジノ−アンスラサイクリン誘導体 | |
| JPS6310712B2 (enrdf_load_stackoverflow) | ||
| US4130648A (en) | 5-Fluorouracil derivatives and antitumor preparations containing the same | |
| Lyttle et al. | 5-Bis (2-Chloroethyl) Aminouracil, a New Anti-tumor Agent | |
| FR2554450A1 (fr) | Glycosides de 4'-halo-anthracycline, procede pour les preparer et leur emploi comme medicament | |
| JPS6041670B2 (ja) | ２，６−ジメチル−１，４−ジヒドロピリジン−３，５−ジカルボン酸エステルおよびその製造方法 | |
| JPS6310958B2 (enrdf_load_stackoverflow) | ||
| JP2000503666A (ja) | Ｍａｐｐｉａ ｆｏｅｔｉｄａから単離したカンプトセシン―骨格化合物および新規な医薬ならびに治療薬のためのシントンとしてのその使用 | |
| FR2459231A1 (fr) | Nouveaux derives de la cystamine utiles comme medicaments | |
| EP0057699A1 (en) | 5,6-o-isoalkylidene ascorbic acid derivatives | |
| JPS58201782A (ja) | 新規１，１０−フエナントロリン誘導体、その製造法および組成物 | |
| US4820706A (en) | Pteridine derivatives and method of treating leukemia employing same | |
| JPS6348877B2 (enrdf_load_stackoverflow) | ||
| JPH06199749A (ja) | Ｎ−メチルデアセチルコルヒセインアミド誘導体 | |
| US4218465A (en) | Glyoxylic acid hydrocarbylsulfonylhydrazones and therapeutic compositions | |
| US3041345A (en) | Process of preparation of isonicotinyl hydrazones and hydrazides | |
| KR820000656B1 (ko) | 아씰화 2-[3-(2-클로로에틸)-3-니트로소우레이도]-2-데옥시-글루코피라노우즈 유도체의 제조방법 | |
| JPS6055077B2 (ja) | ニトロソ尿素誘導体及びその製法 | |
| JPS6125707B2 (enrdf_load_stackoverflow) | ||
| BE1001262A4 (fr) | Procede en vue de provoquer la regression de la leucemie et l'inhibition de la croissance des tumeurs chez les mammiferes. |